Literature DB >> 19467797

Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer.

Robert Y Kim1, Sui Shen, Hui-Yi Lin, Sharon A Spencer, Jennifer De Los Santos.   

Abstract

PURPOSE: To investigate the effects of bladder distension on organs at risk (OARs) in the image-based planning of intracavitary brachytherapy for cervical cancer. METHODS AND MATERIALS: Thirteen patients with cancer of the cervix were treated with high-dose radiation brachytherapy (800 cGy/fraction for 3 fractions). For the three-dimensional (3D) analysis, pelvic CT scans were obtained from patients with indwelling catheters in place (defined as empty bladder) and from patients who received 180-cc injections of sterile water in their bladders (defined as full bladder). To compare the International Commission on Radiation Units and Measurements (ICRU) point doses with 3D-volume doses, the volume dose was defined by using two different criteria, D(2cc) (the minimum dose value in a 2.0-cm(3) volume receiving the highest dose) and D(50%) (the dose received by 50% of the volume of the OAR) for OARs.
RESULTS: The bladder D(2cc) was located more cranially in the bladder base and was distributed in multiple spots in 46% of patients. The rectal D(2cc) was located in the area of the ICRU point as a single "hot spot." For patients with a full bladder, the mean bladder D(2cc) increased from 634 to 799 cGy (28.8%, p = 0.002). However, the bowel D(2cc) decreased from 475 to 261 cGy (45.0%, p < 0.001). There were no substantial differences in rectal and sigmoid D(2cc) values. However, the mean D(50%) values of both the bladder and the bowel decreased from 108 to 80 cGy (23.7%, p < 0.001) and from 282 to 221 cGy (19.7%, p = 0.004) with a full bladder, respectively.
CONCLUSIONS: An increase in bladder volume resulted in a significant reduction in bowel D(2cc) values at the expense of an increase in bladder D(2cc) values. Treatment with a distended bladder is preferable to protect the bowel. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19467797     DOI: 10.1016/j.ijrobp.2009.02.002

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Computed tomography-based three-dimensional dosimetry of intracavitary brachytherapy for cervical cancer.

Authors:  Koichi Wadasaki; Yoshio Monzen; Taichi Kurose; Hajime Okazaki; Mio Mito
Journal:  Jpn J Radiol       Date:  2010-12-30       Impact factor: 2.374

2.  Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy.

Authors:  S Sabater; Ma M Sevillano; I Andres; R Berenguer; S Machin-Hamalainen; K Müller; M Arenas
Journal:  Strahlenther Onkol       Date:  2013-09-04       Impact factor: 3.621

3.  Four-Dimensional Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Systematic Review and Meta-Regression Analysis.

Authors:  Fei Li; Dan Shi; Mingwei Bu; Shuangchen Lu; Hongfu Zhao
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

4.  Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy: A prospective trial.

Authors:  Sebastià Sabater; Ignacio Andrés; Marina Gascon; Angeles Rovirosa; Marimar Sevillano; Roberto Berenguer; Cristina Camacho-Lopez; Manuel Aguayo; Maria Victoria Villas; Meritxell Arenas
Journal:  Strahlenther Onkol       Date:  2016-01-23       Impact factor: 3.621

5.  High-dose-rate interstitial brachytherapy for gynecologic malignancies--dosimetric changes during treatment period.

Authors:  Tsuyoshi Onoe; Takayuki Nose; Hideomi Yamashita; Minoru Yoshioka; Takashi Toshiyasu; Takuyo Kozuka; Masahiko Oguchi; Keiichi Nakagawa
Journal:  J Radiat Res       Date:  2013-01-07       Impact factor: 2.724

6.  Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer.

Authors:  Ozan C Guler; Cem Onal; Ibrahim Acibuci
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

7.  Effect of bladder distension on dosimetry of organs at risk in computer tomography based planning of high-dose-rate intracavitary brachytherapy for cervical cancer.

Authors:  Niladri B Patra; Kazi S Manir; Swapnendu Basu; Jyotirup Goswami; Apurba K Kabasi; Shyamal K Sarkar
Journal:  J Contemp Brachytherapy       Date:  2013-03-29

8.  Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer.

Authors:  Sang Gyu Ju; Seung Jae Huh; Jung Suk Shin; Won Park; Heerim Nam; Sunhyun Bae; Dongryul Oh; Chae-Seon Hong; Jin Sung Kim; Youngyih Han; Doo Ho Choi
Journal:  J Radiat Res       Date:  2012-10-26       Impact factor: 2.724

9.  Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy.

Authors:  Zahra Siavashpour; Mahmoud Reza Aghamiri; Ramin Jaberi; Hamid Reza Dehghan Manshadi; Reza Ghaderi; Christian Kirisits
Journal:  J Contemp Brachytherapy       Date:  2016-04-29

10.  Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.

Authors:  Xianliang Wang; Jie Li; Pei Wang; Ke Yuan; Gang Yin; Bin Wan
Journal:  J Contemp Brachytherapy       Date:  2016-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.